| 12th May 2023 9:50 am |
RNS |
MenABCWY vaccine preliminary phase III results |
| 12th May 2023 7:05 am |
RNS |
Statement: Zantac Litigation Update BC Canada |
| 12th May 2023 7:00 am |
RNS |
GSK completes sale of shares in Haleon plc |
| 11th May 2023 4:41 pm |
RNS |
GSK announces intention to sell shares in Haleon |
| 9th May 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 4th May 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 3rd May 2023 6:20 pm |
RNS |
Result of AGM |
| 3rd May 2023 6:00 pm |
RNS |
US FDA approves GSK’s RSV vaccine for older adults |
| 3rd May 2023 9:09 am |
RNS |
Form 8.3 - Allergy Therapeutics plc |
| 2nd May 2023 3:00 pm |
RNS |
Total Voting Rights |
| 28th Apr 2023 5:01 pm |
RNS |
Director/PDMR Shareholding |
| 27th Apr 2023 7:00 am |
RNS |
GSK RSV OA vaccine gains positive EMA CHMP opinion |
| 26th Apr 2023 7:00 am |
RNS |
1st Quarter Results |
| 25th Apr 2023 7:00 am |
RNS |
EMA validates Jemperli filing for new indication |
| 20th Apr 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 19th Apr 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 18th Apr 2023 7:00 am |
RNS |
GSK reaches agreement to acquire BELLUS Health Inc |
| 17th Apr 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 17th Apr 2023 7:00 am |
RNS |
Gepotidacin positive phase III data |
| 3rd Apr 2023 3:00 pm |
RNS |
Total Voting Rights |
| 28th Mar 2023 7:00 am |
RNS |
Positive phase III RUBY results for Jemperli |
| 27th Mar 2023 1:00 pm |
RNS |
Publication of 2023 AGM Notice |
| 24th Mar 2023 9:59 am |
RNS |
Statement: Zantac (ranitidine) litigation |
| 21st Mar 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 20th Mar 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 14th Mar 2023 7:05 am |
RNS |
Positive phase III results for MenABCWY vaccine |
| 14th Mar 2023 7:00 am |
RNS |
Nucala NDA accepted for review in China |
| 13th Mar 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 10th Mar 2023 4:26 pm |
RNS |
GSK Annual Report 2022 on Form 20-F |
| 10th Mar 2023 10:36 am |
RNS |
GSK publishes Annual Report 2022 |
| 2nd Mar 2023 7:00 am |
RNS |
FDA Ad Com votes to support GSK RSV OA vaccine |
| 1st Mar 2023 3:00 pm |
RNS |
Total Voting Rights |
| 27th Feb 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 23rd Feb 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 23rd Feb 2023 7:00 am |
RNS |
ViiV Healthcare announces Cabenuva positive data |
| 22nd Feb 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 16th Feb 2023 7:00 am |
RNS |
NEJM publishes GSK RSV OA vaccine candidate trial |
| 15th Feb 2023 4:04 pm |
RNS |
Director/PDMR Shareholding |
| 15th Feb 2023 4:00 pm |
RNS |
Director/PDMR Shareholding |
| 14th Feb 2023 7:00 am |
RNS |
Director/PDMR Shareholding |
